Tissue Regenix appoints non-executive director
pharmafile | July 11, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | tissue regenix
Regenerative medical devices firm Tissue Regenix has appointed Randeep Singh Grewal as its non-executive director of the Group.
Grewal has 15 years’ experience working in the institutional investment arena and, until December 2012, was a senior portfolio manager and member of the European equities team at F&C Asset Management.
He has also held investment analyst and portfolio management roles at ICAP Equities and Tudor Capital, where he spent 10 years covering and investing in healthcare companies.
Grewal has considerable entrepreneurial expertise, having been involved in a number of start-up companies, both personally and as an investor, and qualified in Medicine from the University of Cambridge.
John Samuel, executive chairman of Tissue Regenix, said: “We are delighted that Randeep is joining the Tissue Regenix Board and he joins us at an exciting time. We are confident that his insight from an investment community perspective, as well as his in-depth knowledge and analysis of the healthcare sector, will play an invaluable role in allowing the Group to progress further in delivering our focused strategy.”






